JPMorgan Chase & Co’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,752
| Closed | -$148K | – | 6079 |
|
|
2022
Q1 | $148K | Sell |
7,752
-442
| -5% | -$8.44K | ﹤0.01% | 4582 |
|
|
2021
Q4 | $294K | Sell |
8,194
-402
| -5% | -$14.4K | ﹤0.01% | 4347 |
|
|
2021
Q3 | $632K | Sell |
8,596
-517
| -6% | -$38K | ﹤0.01% | 3845 |
|
|
2021
Q2 | $1.27M | Sell |
9,113
-1,377
| -13% | -$192K | ﹤0.01% | 3495 |
|
|
2021
Q1 | $3.05M | Buy |
+10,490
| New | +$3.05M | ﹤0.01% | 2979 |
|